Announcements Trials
Browse Landscape

Phase

Phase 2 62Phase 1/2 14Phase 3 9Phase NA 3Phase 4 3Phase 2/3 3Phase EARLY_PHASE1 2Phase 1 2

Status

Completed 166Recruiting 41Terminated 32Active not recruiting 17Unknown 10Withdrawn 7Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Glioma 1Glioblastoma 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 21fludarabine 17Specimen Handling 13Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 9Radiotherapy 7Cisplatin 7fludarabine phosphate 5Injections 5tislelizumab 4daratumumab 4Rituximab 4Paclitaxel 4Ipilimumab 4Interleukin-2 4Immune Checkpoint Inhibitors 4Gemcitabine 4Fluorouracil 4Drug Therapy 4Doxorubicin 4Dexamethasone 4Carboplatin 4Biopsy 4venetoclax 3toripalimab 3X-Rays 3Radiosurgery 3Platinum 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Bevacizumab × Clear all
NCT07541781 2026-04-21

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

University of Iowa

Phase 1 Not yet recruiting
45 enrolled
CNS

Glioblastoma, Glioma

NCT06882915 2025-03-19

Efficacy and Safety of Trifluridine/tipiracil (TAS-102) Combined with Bevacizumab and Putalimab in the Treatment of Patients with MCRC After Cytoreductive Surgery: a Single-arm, Single-center Clinical Study

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Not yet recruiting
20 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡